Announced details
Rapid diagnosis and public health measures for Ebola virus disease and Bundibugyo virus infection
The expected specification is for results to be obtained within 15 minutes. The system is expected to maintain sensitivity equivalent to that of existing real-time PCR methods and to be usable with multiple real-time PCR instruments.
The Company applied to GHIT Fund for the research and development project and was selected as the lead research institution.
An international public-private partnership originating in Japan, involving the Japanese government, private-sector companies and the Gates Foundation, among others. It supports the research and development of therapeutics, vaccines, diagnostic products and other technologies for infectious diseases prevalent mainly in developing countries. Location, representative, capital and year established: not disclosed
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Prototype LAMP-based test reagent and rapid diagnostic system for detecting Bundibugyo virus (BDBV) |
| Counterparty | Global Health Innovative Technology Fund (GHIT Fund) |
| Counterparty overview | An international public-private partnership originating in Japan, involving the Japanese government, private-sector companies and the Gates Foundation, among others. It supports the research and development of therapeutics, vaccines, diagnostic products and other technologies for infectious diseases prevalent mainly in developing countries. Location, representative, capital and year established: not disclosed |
| Relationship with the Company | The Company applied to GHIT Fund for the research and development project and was selected as the lead research institution. |
| Launch date | Not disclosed (the Company aims to complete prototype development within a short period) |
| Applicable area | Rapid diagnosis and public health measures for Ebola virus disease and Bundibugyo virus infection |
| Quantitative Effects | The expected specification is for results to be obtained within 15 minutes. The system is expected to maintain sensitivity equivalent to that of existing real-time PCR methods and to be usable with multiple real-time PCR instruments. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To respond to the spread of Ebola virus disease caused by Bundibugyo virus and facilitate the early identification of infected individuals, followed by isolation, medical care and contact-tracing measures.